We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 33

Refusal to sell software punished as an abuse of dominance

  • Bryan Cave LLP
  • -
  • France
  • -
  • August 6 2014

Pursuant to a complaint in 2008 by Euris (a French company specialising in customer relations management (CRM) software for the pharmaceutical

Focus on regulatory law - July 2014

  • McDermott Will & Emery
  • -
  • France
  • -
  • July 16 2014

Having been notified of an appeal against the Competition Authority’s decision regarding a joint acquisition of retail trade warehouses, the Conseil

The case of ophthalmic drugs in Italy and France: a lesson to learn - parallel antitrust investigations and cooperation between national competition authorities

  • McDermott Will & Emery
  • -
  • European Union, France, Italy
  • -
  • May 7 2014

The recent investigations into two pharmaceutical companies active in the ophthalmic drugs market in Italy and France serve as a reminder of the

French legal and regulatory update - April 2014

  • Hogan Lovells
  • -
  • European Union, France
  • -
  • May 1 2014

Draft law granting amnesty for acts committed in the course of social movements and trade unions' protesting activities Filed on November 28, 2012

Sidley Austin LLP global pricing newsletter - volume three 2014

  • Sidley Austin LLP
  • -
  • Brazil, Canada, China, European Union, France, Germany, India, United Kingdom, USA
  • -
  • April 15 2014

On October 21, 2013, Brazil’s National Agency of Supplemental Health enacted Normative Resolution 388, which mandated that all private healthcare

French Competition Authority fines pharmaceutical Laboratory EUR 15.3 million for hindering the launch of generic equivalent

  • Bryan Cave LLP
  • -
  • France
  • -
  • March 14 2014

In an important decision of December 18, 2013, the French Competition Authority ("FCA") fined Schering-Plough and its parent companies a total of EUR

Johnson & JohnsonNovartis another challenge to pay for delay: is this ever permissible?

  • Bryan Cave LLP
  • -
  • European Union, France, Germany, Italy, United Kingdom
  • -
  • January 14 2014

In the latest challenge to so-called “pay for delay” or “reverse payment” agreements, on 10 December 2013, the European Commission fined the

France - Public consultation into the pharmaceutical sector

  • Hogan Lovells
  • -
  • France
  • -
  • September 1 2013

The French Competition Authority has launched on 10 July 2013 a public Consultation entitled "How to revitalize competition in the distribution of

The Autorité de la concurrence French Competition Authority is launching a public consultation on the distribution of medicinal products in private practices.

  • Baker & McKenzie
  • -
  • France
  • -
  • July 24 2013

The Autorité de la concurrence ("Autorité") has submitted its preliminary assessment to a public consultation on 10 July 2013 on the

Life sciences: 2013 legal developments you need to know about

  • Mayer Brown LLP
  • -
  • China, European Union, France, USA
  • -
  • July 16 2013

This is a short guide outlining some of the key legal developments in the life sciences sector in 2013. The developments include the Supreme Court